홈
탐색
nav.journalClub
트렌드
더보기
synapse
⌘+K
언어
한국어
한국어
Spinal Muscular Atrophy (SMA) | Synapse
March 3, 2026
Spinal Muscular Atrophy (SMA)
KR
Kaitlyn Rodriguez
MK
Mara Karamitopoulos
Key Points
Spinal muscular atrophy (SMA) severity was linked to specific biomarkers, indicating treatment pathways.
Interventions investigated included genetic therapies aiming to enhance muscle function in SMA patients.
Assessment analyzed the physiological systems impacted by SMA, revealing critical insights for potential therapies.
Findings underscore the significance of early diagnosis and intervention, which may improve patient outcomes.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Rodriguez et al. (Sun,) studied this question.
synapsesocial.com/papers/69a761e0c6e9836116a2ff2e
https://doi.org/https://doi.org/10.1016/j.oto.2026.101213
Mark Helpful
Like
Save
Bookmark
Relay
Share